Maxis AI Introduces the First Verticalized Context Layer for Life Sciences, a Governed Execution Fabric That Makes Enterprise AI Reliable, Cost-Efficient, and Regulatory Compliant
Maxis AI today introduced MaxisAI Holarchy, its Verticalized Context Layer, a governed institutional memory that gives life sciences enterprises the trusted organizational context AI agents need to support clinical execution across the development lifecycle. It sits between every AI agent and every model; grounds each call in the standards, compliance, and policies an organization runs on; checks it against the rules its regulator enforces; and seals the whole path into an inspection-ready record. It is available as an independent product or within the MaxisAI platform.
MaxisIT Evolves to Maxis AI, Launches Enterprise-Ready Agentic AI Platform to Transform Clinical Trials in Pharmaceutical and Life Sciences IndustryEDISON, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- MaxisIT, a long-recognized provider of clinical data analytics platform for clinical trials, today announced its transformation into Maxis AI. This strategic evolution is marked by the introduction of the company's innovative Agentic AI Platform, launched with the guiding principle: "Designed to Think. Built to Act." This initiative signals a new direction for clinical development. As part of this change, Maxis AI’s new platform will support pharmaceutical and life sciences companies in achieving greater efficiency, deeper insights, and accelerated progress.
